Related Experiment Videos
Steroidogenesis in menopause and endometrial pathology
Clinical and Experimental Obstetrics & Gynecology
|January 1, 1981
Summary
Postmenopausal women with endometrial cancer have higher estradiol levels, linked to body weight, not ovarian or adrenal steroidogenesis. This suggests estradiol
Area of Science:
- Endocrinology
- Gynecologic Oncology
- Reproductive Biology
Background:
- Postmenopausal steroidogenesis involves ovarian and adrenal contributions.
- Estrogen levels, particularly estradiol, are implicated in hormone-dependent diseases.
Purpose of the Study:
- To review literature on postmenopausal steroidogenesis.
- To compare sex-hormone levels in endometrial cancer patients versus controls.
- To investigate the role of estradiol in endometrial cancer pathogenesis.
Main Methods:
- Literature review of postmenopausal steroidogenesis.
- Comparison of sex-hormone levels between endometrial cancer patients and controls.
- Analysis of estradiol levels in relation to body weight.
Main Results:
- Estradiol levels are higher in postmenopausal endometrial cancer patients compared to controls.
- This difference is primarily associated with higher body weight in cancer patients.
- When matched for body weight, no significant difference in estradiol levels was observed.
Conclusions:
- Body weight, not altered steroidogenesis, appears to be the main factor for higher estradiol levels in postmenopausal endometrial cancer.
- Estradiol's role in endometrial cancer pathogenesis is supported by its association with body weight in affected individuals.